Tag: chemistry
-
Janssen, Biotech Partner on Drug Delivery Technology
17 December 2014. Halozyme Therapeutics, a biotechnology company in San Diego, is licensing its drug delivery technology for under-the-skin injections to Janssen Biotech, one of the Janssen Pharmaceutical companies and a division of Johnson & Johnson. The deal is expected to bring Halozyme up to $581 million in initial and milestone payments. Halozyme develops synthetic…
-
Nanomedicine Developer Secures $7.5M Venture Funds
15 December 2014. Cristal Therapeutics, a developer of medications formulated as nanoscale particles, raised more than €6 million ($7.5 million) in early-stage venture funds. The financing round for the company, based in Maastricht, The Netherlands, was led by Chemelot Ventures, with current seed investors Thuja Capital, BioGeneration Ventures, Nedermaas, Utrecht University Holding, and Beheer Innovatiefonds…
-
Patent Awarded for Macular Degeneration Eyedrop Technology
4 December 2014. SciFluor Life Sciences LLC, a biopharmaceutical company in Cambridge, Massachusetts received a patent on a fluoride formulation for treating diseases of the retina with eyedrops rather than injections into the eye as often required. Patent 8,901,144 was awarded on 2 December by the U.S. Patent and Trademark Office to four inventors, including…
-
Peptide Regenerates Muscles Damaged from Spinal Cord Injury
4 December 2014. Researchers at Case Western Reserve University developed a synthetic peptide that in lab animals restores some functions in muscles damaged from spinal cord injuries. The team from the lab of CWRU neuroscientist Jerry Silver in Cleveland, Ohio published its findings yesterday in the journal Nature (paid subscription required). National Institute of Neurological…
-
High-Speed Artery Imaging Technology in Development
5 November 2014. A process to capture high-speed three-dimensional images of plaque deposits in arteries and analyze their chemical makeup for diagnosing heart conditions is being developed by Purdue University in West Lafayette, Indiana. The team from the lab of Purdue biomedical engineer and chemist Ji-Xin Cheng, with colleagues from Indiana University School of Medicine,…
-
Patent Issued for Engineered Peptides Forming Hydrogels
4 November 2014. Bioengineers at Kansas State University received a patent for their invention of a peptide, a protein-like compound, that turns into water-based gels for a number of medical applications. U.S. Patent and Trademark Office awarded patent number 8,835,395 to Xiuzhi (Susan) Sun, professor of grain science and bioengineering at Kansas State, as well…
-
Synthetic Blood Thinner Antidote Developed
30 October 2014. Medical and biochemical researchers at University of British Columbia in Vancouver, Canada designed a polymer antidote for heparin that in lab animals neutralizes anti-coagulant activity and appears to be well tolerated. The team led by chemistry and pathology professor Jayachandran Kizhakkedathu published its findings yesterday in the journal Science Translational Medicine (paid subscription…
-
FDA Exemption Sought for Ebola Blood Plasma Device
20 October 2014. Cerus Corp., a developer of blood safety devices, is asking the U.S. Food and Drug Administration to allow its system for removing pathogens from blood plasma be used to treat patients in the U.S. with Ebola, while the device is under review. The provision, called a Compassionate Use Investigational Device Exemption, allows…
-
Simple 3-D Graphene Construction Process Devised
17 October 2014. Materials scientists at Kyoto University in Japan developed a new process that simplifies the building of three-dimension structures with graphene, a light, strong, conductive material with many industrial and commercial applications. Franklin Kim and Jianli Zou from Kyoto’s Institute for Integrated Cell-Material Sciences published their findings yesterday in the journal Nature Communications…
-
New Coating Material Stops Blood Clots, Bacterial Films
13 October 2014. Engineers and medical researchers at Harvard University developed a material to coat tubes in medical devices that repels blood, preventing clots from forming and reducing the need for blood-thinning drugs. The new material from Harvard’s Wyss Institute for Biologically Inspired Engineering and collaborators at affiliated labs and hospitals is described in an…